EGFR and bone neoplasm: We found that orthotopic bone tumors induced with the EGFR and c‐Fos expressing 143b OS cell line were responsive to anti‐EGFR treatment, whereas LM7 cells, which only express EGFR but not c‐Fos, did not respond to erlotinib.